Control Organisation News Today

A notification of the revised Schedule M rules by the Ministry of Health and Family Welfare has elicited mixed responses from the pharma sector and industry observers. While the industry has welcomed the revision of rules, several analysts said that implementation and compliance can become a challenge for smaller pharmaceutical companies. The Schedule M of the Drugs and Cosmetics Rules specifies the good manufacturing practices (GMPs), which aim to ensure quality of drugs made in the country.

Read more about Haryana court convicts two pharma company senior executives, awards jail term on Devdiscourse

After the World Health Organization (WHO) warned that it suspected four cough syrups could be linked to the deaths of 66 children in Gambia, the Delhi-based manufacturer, Maiden Pharmaceuticals, is in the news. The syrups, the WHO said, have been “potentially linked with acute kidney injuries and 66 deaths among children.” The global body also

The Supreme Court has issued notice to the Central government, National AIDS Control Organisation and others on a plea alleging a shortage of antiretroviral dru

National Medical Device Promotion Council takes up important issues of the medtech industry

This paper considers the dance and activist labour of a group of cis- and transgendered performers who lobby for the decrimininalisation of sex work in India. Known as Komal Gandhar, the group operate out of Sonagachi, Kolkata and are the cultural wing of the Durbar Mahila Samanwaya Committee, a collective of over 65,000 sex workers. Based on in-depth interviews with Komal

Note: This manual is under review following Brexit and is likely to be withdrawn. If there is anything within this manual you use regularly, please email <hmrcmanualsteam@hmrc.gov.uk> to let us know. Please check the other guidance available on GOV.UK from HMRC. Risk assessment and offence action about the control of export and transhipment of goods that require licences issued by the Department for International Trade.

The Covid vaccination drive for the 12 to 14 years age group will start only after more scientific data evolves, Union Health Secretary Rajesh Bhushan said on Thursday.

The Covid vaccination drive for the 12 to 14 years age group will start only after more scientific data evolves, Union Health Secretary Rajesh Bhushan said on Thursday."As scientific evidence evolves, we will be expanding the coverage of ...

Justices L. Nageswara Rao and B.R. Gavai agreed to examine the matter after Prashant Bhushan sought an early hearing of the application moved by Dr Jacob Puliyel